27 Feb 2019 --- Research has uncovered new biological pathways by which the microalgae compound fucoidan could tackle cancer cells. A new in vitro study conducted at the University of Tasmania, Australia, used Maritech fucoidan produced by Australian biotechnology company Marinova. The findings showed that fucoidan can limit cancer cells in their ability to make proteins, utilize energy and repair damage to themselves. Marinova highlights the seaweed-derived bioactive extract’s potential as an adjunct to cancer treatment.
